Daniel Eitutis practices general corporate and securities law, with an emphasis on representing emerging growth companies and venture capital funds in a wide range of transactions.

Download full bio 

Experience

  • Vera Therapeutics – $48 Million IPO 

  • Spruce Biosciences – $130 Million IPO 

Education

  • Queen's University
    JD, 2016

  • Queen's University
    BA, Philosophy
    2013


Admissions & Credentials

California

Ontario, Canada